Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Akebia Therapeutics

Biotech & Life Sciences · Cambridge, United States · Founded 2007 · IPO 2014 Thoroughbred

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$229M
Market cap · Apr/2026
Revenue
$236M
Latest reported FY

Investors

11 investors on Akebia Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Seed 1 investor entered at this stage
CincyTech
Series A 6 investors entered at this stage
Venture Investors Health Fund
Orchard Venture Partners
Novartis Venture Fund
Kearny Venture Partners
Athenian Venture Partners
Triathlon Medical Venture Partners
Series B+ 4 investors entered at this stage
QCA Ventures
GeneChem
Novo Holdings
Novo Seeds

Global footprint

Where Akebia Therapeutics has talent and traffic

AI talent share
0.4% of workforce is AI talent
(1 of 271 staff)
Core AI00%
Other AI10.37%
Non-AI workforce27099.63%
Web traffic by country
10K monthly visits
across markets
🇺🇸 United States48%
🇭🇰 Hong Kong15%
🇬🇧 United Kingdom13%
🇮🇳 India13%
🇨🇦 Canada10%
Top 5 markets shown

See Akebia Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo